Publications

Journal Article
Research Support, U.S. Gov't, P.H.S.
Ppublish 230 citations
Electronic publication date
March 28, 2001

View on Pubmed.gov 8822909 View on doi.org

Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases.

Search for publications in this journal Blood - 88(6):1930-5

Abstract

Loss of a whole chromosome 7 or a deletion of the long arm, del(7q), are recurring abnormalities in malignant myeloid diseases. To determine the location of genes on 7q that are likely to play a role in leukemogenesis, we examined the deleted chromosome 7 homologs in a series of 81 patients with therapy-related or de novo myelodysplastic syndrome or acute myeloid leukemia. Our analysis showed that the deletions were interstitial and that there were two distinct deleted segments of 7q. The majority of patients (65 of 81 [80%]) had proximal breakpoints in bands q11-22 and distal breakpoints in q31-36; the smallest overlapping deleted segment was within q22. The remaining 16 patients had deletions involving the distal q arm with a commonly deleted segment of q32-33. To define the proximal deleted segment at 7q22 at a molecular level, we used fluorescence in situ hybridization with a panel of mapped yeast artificial chromosome (YAC) clones from 7q to examine 15 patients with deletion breakpoints in 7q22. We determined that the smallest overlapping deleted segment is contained in a well-defined YAC contig that spans 2 to 3 Mb. These studies delineate the region of 7q that must be searched to isolate a putative myeloid leukemia suppressor gene, and provide the necessary cloned DNA for more detailed physical mapping and gene isolation.

References

No references provided.

Cited by 230 citations (total)

Journal Article Research Support, N.I.H., Extramural Review

Myelodysplastic syndromes.

Electronic publication date June 1, 2012

Search for publications in this journal Clin Lab Med

Olatoyosi Odenike [...] Michelle M Le Beau et al.

The myelodysplastic syndromes are a diverse group of clonal stem cell disorders characterized by ineffective hematopoiesis, peripheral cytopenias, and an...

Journal Article

Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy.

Electronic publication date August 4, 2011

Search for publications in this journal Adv Hematol

Amir T Fathi [...] Omar Abdel-Wahab et al.

In the recent years, the discovery of a series of mutations in patients with myeloid malignancies has provided insight into...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties